Calvet D, Bernaudin F, Gueguen A et al (2015) First Ischemic Stroke in Sickle-Cell Disease. Stroke 46:2315–2317. https://doi.org/10.1161/STROKEAHA.115.010153
Article CAS PubMed Google Scholar
Kirkham FJ, Lagunju IA (2021) Epidemiology of Stroke in Sickle Cell Disease. J Clin Med 10:4232. https://doi.org/10.3390/jcm10184232
Article CAS PubMed PubMed Central Google Scholar
Switzer JA, Hess DC, Nichols FT, Adams RJ (2006) Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 5:501–512. https://doi.org/10.1016/S1474-4422(06)70469-0
Gueguen A, Mahevas M, Nzouakou R et al (2014) Sickle-cell disease stroke throughout life: A retrospective study in an adult referral center. Am J Hematol 89:267–272. https://doi.org/10.1002/ajh.23625
DeBaun MR, Jordan LC, King AA et al (2020) American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv 4:1554–1588. https://doi.org/10.1182/bloodadvances.2019001142
Article CAS PubMed PubMed Central Google Scholar
Light J, Boucher M, Baskin-Miller J, Winstead M (2023) Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives. J Blood Med Volume 14:279–293. https://doi.org/10.2147/JBM.S383472
Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. https://doi.org/10.1161/STR.0000000000000211. Stroke 50:
Ferriero DM, Fullerton HJ, Bernard TJ et al (2019) Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. https://doi.org/10.1161/STR.0000000000000183. Stroke 50:
Buompadre MC, Andres K, Slater L-A et al (2017) Thrombectomy for Acute Stroke in Childhood: A Case Report, Literature Review, and Recommendations. Pediatr Neurol 66:21–27. https://doi.org/10.1016/j.pediatrneurol.2016.09.007
Alakbarzade V, Maduakor C, Khan U et al (2023) Cerebrovascular disease in sickle cell disease. Pract Neurol 23:131–138. https://doi.org/10.1136/pn-2022-003440
Adams RJ, Cox M, Ozark SD et al (2017) Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke. Stroke 48:686–691. https://doi.org/10.1161/STROKEAHA.116.015412
Dobson SR, Holden KR, Nietert PJ et al (2002) Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99:3144–3150. https://doi.org/10.1182/blood.V99.9.3144
Article CAS PubMed Google Scholar
Kang S, Liu X, Zhang D et al (2019) Natural Course of Moyamoya Disease in Patients With Prior Hemorrhagic Stroke. Stroke 50:1060–1066. https://doi.org/10.1161/STROKEAHA.118.022771
Kassim AA, Galadanci NA, Pruthi S, DeBaun MR (2015) How I treat and manage strokes in sickle cell disease. Blood 125:3401–3410. https://doi.org/10.1182/blood-2014-09-551564
Article CAS PubMed PubMed Central Google Scholar
Bernaudin F, Dalle J-H, Bories D et al (2020) Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France. Haematologica 105:91–101. https://doi.org/10.3324/haematol.2018.213207
Article PubMed PubMed Central Google Scholar
Rigano P, De Franceschi L, Sainati L et al (2018) Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent. Blood Cells Mol Dis 69:82–89. https://doi.org/10.1016/j.bcmd.2017.08.017
Article CAS PubMed Google Scholar
Guilliams KP, Kirkham FJ, Holzhauer S et al (2019) Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke Management. Stroke 50:1089–1094. https://doi.org/10.1161/STROKEAHA.118.022800
Article PubMed PubMed Central Google Scholar
SPREAD (2016) Ictus cerebrale: linee guida italiane di prevenzione e trattamento. Italy
DeBaun MR, Armstrong FD, McKinstry RC et al (2012) Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 119:4587–4596. https://doi.org/10.1182/blood-2011-02-272682
Article CAS PubMed PubMed Central Google Scholar
Early ML, Linton E, Bosch A et al (2022) The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains. Br J Haematol 198:382–390. https://doi.org/10.1111/bjh.18188
Article PubMed PubMed Central Google Scholar
Prussien KV, Jordan LC, DeBaun MR, Compas BE (2019) Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis. J Pediatr Psychol 44:948–958. https://doi.org/10.1093/jpepsy/jsz031
Article PubMed PubMed Central Google Scholar
Mills J-A, Cieza A, Short SD, Middleton JW (2021) Development and Validation of the WHO Rehabilitation Competency Framework: A Mixed Methods Study. Arch Phys Med Rehabil 102:1113–1123. https://doi.org/10.1016/j.apmr.2020.10.129
Article PubMed PubMed Central Google Scholar
Ehlhardt LA, Sohlberg MM, Kennedy M et al (2008) Evidence-based practice guidelines for instructing individuals with neurogenic memory impairments: What have we learned in the past 20 years? Neuropsychol Rehabil 18:300–342. https://doi.org/10.1080/09602010701733190
WHO (2020) Fact sheets: Rehabilitation. https://www.who.int/news-room/fact-sheets/detail/rehabilitation. Accessed 7 Oct 2024
Nature research custom media, Children’s Hospital of Philadelphia (2023) A cure for sickle cell disease is taking shape. https://www.nature.com/articles/d42473-023-00151-3. Accessed 7 Oct 2024
留言 (0)